Table 2.
Correlation of ARPC2 expression with clinicopathological parameters from gastric cancer patients.
| Parameter | n | ARPC2 expression | |
|---|---|---|---|
| Positive, n (%) | P value | ||
| Age (years) | |||
| ≤60 | 57 | 34 (59.6) | 0.367 |
| >60 | 53 | 36 (67.9) | |
| Gender | |||
| Male | 60 | 34 (56.7) | 0.096 |
| Female | 50 | 36 (72.0) | |
| Tumor size (cm) | |||
| ≤5 | 73 | 38 (52.1) | 0.001 |
| >5 | 37 | 32 (86.5) | |
| Lymph node metastasis | |||
| No | 34 | 15 (44.1) | 0.004 |
| Yes | 76 | 55 (72.4) | |
| Grade | |||
| I | 11 | 8 (72.7) | 0.638 |
| II | 71 | 43 (60.6) | |
| III | 28 | 19 (67.9) | |
| Stage | |||
| I-II | 57 | 25 (43.9) | 0.001 |
| III-IV | 53 | 45 (84.9) | |